Advertisement
Heart Rhythm
Advanced searchSave search
Hands on| Volume 3, ISSUE 5, P615-618, May 2006

How to select patients for atrial fibrillation ablation

  • Hakan Oral
    Correspondence
    Address reprint requests and correspondence: Dr. Hakan Oral, Division of Cardiovascular Medicine, University of Michigan, TC B1 140D, Electrophysiology, 1500 East Medical Center Drive, Ann Arbor, Michigan 48109-0311.
    Affiliations
    Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, Michigan.
    Search for articles by this author
  • Fred Morady
    Affiliations
    Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, Michigan.
    Search for articles by this author
Published:January 25, 2006DOI:https://doi.org/10.1016/j.hrthm.2006.01.016
How to select patients for atrial fibrillation ablation
Previous ArticlePacemaker troubleshooting: When MVP is not the most valuable parameter
Next ArticleCardiac resynchronization therapy in a patient with isolated noncompaction of the left ventricle and a narrow QRS complex
      The goals of therapy for atrial fibrillation (AF) are elimination of symptoms and improvement in quality of life; prevention of complications such as thromboembolic events and tachycardia-mediated cardiomyopathy; and, at least in theory, improvement in survival.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Heart Rhythm
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Hsu L.F.
        • Jais P.
        • Sanders P.
        • Garrigue S.
        • Hocini M.
        • Sacher F.
        • Takahashi Y.
        • Rotter M.
        • Pasquie J.L.
        • Scavee C.
        • Bordachar P.
        • Clementy J.
        • Haissaguerre M.
        Catheter ablation for atrial fibrillation in congestive heart failure.
        N Engl J Med. 2004; 351: 2373-2383
        View in Article
        • Lemola K.
        • Sneider M.
        • Desjardins B.
        • Case I.
        • Chugh A.
        • Hall B.
        • Cheung P.
        • Good E.
        • Han J.
        • Tamirisa K.
        • Bogun F.
        • Pelosi Jr, F.
        • Kazerooni E.
        • Morady F.
        • Oral H.
        Effects of left atrial ablation of atrial fibrillation on size of the left atrium and pulmonary veins.
        Heart Rhythm. 2004; 1: 576-581
        View in Article
        • Oral H.
        • Pappone C.
        • Chugh A.
        • Good E.
        • Bogun F.
        • Pelosi Jr, F.
        • Bates E.
        • Lehmann M.
        • Vicedomini G.
        • Augello G.
        • Agricola E.
        • Sala S.
        • Santinelli V.
        • Morady F.
        Circumferential pulmonary vein ablation for chronic atrial fibrillation.
        N Engl J Med. 2006; 354: 934-941
        View in Article
        • Lemola K.
        • Desjardins B.
        • Sneider M.
        • Case I.
        • Chugh A.
        • Good E.
        • Han J.
        • Tamirisa K.
        • Tsemo A.
        • Reich S.
        • Tschopp D.
        • Igic P.
        • Elmouchi D.
        • Bogun F.
        • Pelosi Jr, F.
        • Kazerooni E.
        • Morady F.
        • Oral H.
        Effect of left atrial circumferential ablation for atrial fibrillation on left atrial transport function.
        Heart Rhythm. 2005; 2: 923-928
        View in Article
        • Wyse D.G.
        • Waldo A.L.
        • DiMarco J.P.
        • Domanski M.J.
        • Rosenberg Y.
        • Schron E.B.
        • Kellen J.C.
        • Greene H.L.
        • Mickel M.C.
        • Dalquist J.E.
        • Corley S.D.
        A comparison of rate control and rhythm control in patients with atrial fibrillation.
        N Engl J Med. 2002; 347: 1825-1833
        View in Article
        • Corley S.D.
        • Epstein A.E.
        • DiMarco J.P.
        • Domanski M.J.
        • Geller N.
        • Greene H.L.
        • Josephson R.A.
        • Kellen J.C.
        • Klein R.C.
        • Krahn A.D.
        • Mickel M.
        • Mitchell L.B.
        • Nelson J.D.
        • Rosenberg Y.
        • Schron E.
        • Shemanski L.
        • Waldo A.L.
        • Wyse D.G.
        Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study.
        Circulation. 2004; 109: 1509-1513
        View in Article
        • Pappone C.
        • Rosanio S.
        • Augello G.
        • Gallus G.
        • Vicedomini G.
        • Mazzone P.
        • Gulletta S.
        • Gugliotta F.
        • Pappone A.
        • Santinelli V.
        • Tortoriello V.
        • Sala S.
        • Zangrillo A.
        • Crescenzi G.
        • Benussi S.
        • Alfieri O.
        Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation.
        J Am Coll Cardiol. 2003; 42: 185-197
        View in Article
        • Kottkamp H.
        • Tanner H.
        • Kobza R.
        • Schirdewahn P.
        • Dorszewski A.
        • Gerds-Li J.H.
        • Carbucicchio C.
        • Piorkowski C.
        • Hindricks G.
        Time courses and quantitative analysis of atrial fibrillation episode number and duration after circular plus linear left atrial lesions: trigger elimination or substrate modification: early or delayed cure?.
        J Am Coll Cardiol. 2004; 44: 869-877
        View in Article
        • Cappato R.
        • Calkins H.
        • Chen S.A.
        • Davies W.
        • Iesaka Y.
        • Kalman J.
        • Kim Y.H.
        • Klein G.
        • Packer D.
        • Skanes A.
        Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation.
        Circulation. 2005; 111: 1100-1105
        View in Article
        • Chan P.
        • Vijan S.
        • Morady F.
        • Oral H.
        Cost-effectiveness of left atrial catheter ablation, antiarrhythmic therapy, and rate control for paroxysmal and chronic atrial fibrillation.
        J Am Coll Cardiol. 2005; 45: 125A
        View in Article
        • Wazni O.M.
        • Marrouche N.F.
        • Martin D.O.
        • Verma A.
        • Bhargava M.
        • Saliba W.
        • Bash D.
        • Schweikert R.
        • Brachmann J.
        • Gunther J.
        • Gutleben K.
        • Pisano E.
        • Potenza D.
        • Fanelli R.
        • Raviele A.
        • Themistoclakis S.
        • Rossillo A.
        • Bonso A.
        • Natale A.
        Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation.
        JAMA. 2005; 293: 2634-2640
        View in Article
        • Lang C.C.
        • Santinelli V.
        • Augello G.
        • Ferro A.
        • Gugliotta F.
        • Gulletta S.
        • Vicedomini G.
        • Mesas C.
        • Paglino G.
        • Sala S.
        • Sora N.
        • Mazzone P.
        • Manguso F.
        • Pappone C.
        Transcatheter radiofrequency ablation of atrial fibrillation in patients with mitral valve prostheses and enlarged atria.
        J Am Coll Cardiol. 2005; 45: 868-872
        View in Article
        • Oral H.
        • Hall B.
        • Chugh A.
        • Cheung P.
        • Lemola K.
        • Good E.
        • Tamirisa K.
        • Han J.
        • Bogun F.
        • Pelosi Jr, F.
        • Morady F.
        Age and catheter ablation for atrial fibrillation (abstr).
        Circulation. 2004; 110: 348
        View in Article

      Article info

      Publication history

      Published online: January 25, 2006

      Identification

      DOI: https://doi.org/10.1016/j.hrthm.2006.01.016

      Copyright

      © 2006 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX